Contemporary OB/GYN week in review: Elinzanetant, MIRA, and more

News
Article

Review some of the top stories from the Contemporary OB/GYN website over the last week, and catch up on anything you may have missed.

Contemporary OB/GYN week in review: Elinzanetant, MIRA, and more

Contemporary OB/GYN week in review: Elinzanetant, MIRA, and more

Thank you for visiting the Contemporary OB/GYN® website. Take a look at some of our top stories from last week (Monday, July 29 - Friday, August 02, 2024), and click each link to read and watch anything you may have missed.

1.) Bayer submits NDA for elinzanetant to treat vasomotor symptoms

Bayer has submitted a New Drug Application for elinzanetant, following positive results from the OASIS studies, showing significant safety and efficacy in treating moderate-to-severe vasomotor symptoms in menopausal women.

Click here for the full article.

2.) First hysterectomy using miniaturized MIRA Surgical System performed

Virtual Incision Corporation has announced the successful performance of the first benign hysterectomy using their miniaturized robotic-assisted surgery device, MIRA, in a clinical trial assessing its safety and efficacy.

Click here for the full article.

3.) Surge in self-managed abortions reported post-Dobbs decision

Following the Supreme Court's Dobbs decision, rates of self-managed abortions have risen significantly, especially among marginalized communities, highlighting growing barriers to accessing legal abortion care.

Click here for the full article.

4.) Gestational carrier pregnancies: Balancing outcomes and risks

A recent study highlights the improved outcomes yet elevated risks associated with gestational carrier pregnancies compared to general pregnancies.

Click here for the full article.

5.) Preeclampsia linked to increased vascular dementia risk

A recent study found that women with preeclampsia during pregnancy face a higher risk of developing vascular dementia, but additional data was needed for other forms of dementia.

Click here for the full article.

Recent Videos
How fezolinetant advances non-hormonal treatment of hot flashes | Image Credit: medschool.cuanschutz.edu
Contraceptive access challenges for college students in contraception deserts | Image Credit: linkedin.com.
March of Dimes 2024 Report highlights preterm birth crisis | Image Credit: marchofdimes.org
Understanding and managing postpartum hemorrhage: Insights from Kameelah Phillips, MD | Image Credit: callawomenshealth.com
Rossella Nappi, MD, discusses benefits of fezolinetant against vasomotor symptoms | Image Credit: imsociety.org
Understanding cardiovascular risk factors in women | Image Credit: cedars-sinai.org.
Updated FLUBLOK label expands influenza vaccine options for pregnant women | Image Credit: mass-vaccination-resources.org
JoAnn Pinkerton discusses elinzanetant's crucial role in VMS therapy | Image Credit: uvahealth.com
Supporting women through menopause with knowledge and care | Image Credit: © SHOTPRIME STUDIO - © SHOTPRIME STUDIO - stock.adobe.com.
Related Content
© 2024 MJH Life Sciences

All rights reserved.